TRDN
Basic information
Region (hg38): 6:123216339-123637189
Links
Phenotypes
GenCC
Source: 
- catecholaminergic polymorphic ventricular tachycardia 5 (Strong), mode of inheritance: AR
- catecholaminergic polymorphic ventricular tachycardia (Supportive), mode of inheritance: AD
- catecholaminergic polymorphic ventricular tachycardia 5 (Strong), mode of inheritance: AR
- catecholaminergic polymorphic ventricular tachycardia 5 (Definitive), mode of inheritance: AR
- familial long QT syndrome (Strong), mode of inheritance: AR
- long QT syndrome (Strong), mode of inheritance: AR
- catecholaminergic polymorphic ventricular tachycardia (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source: 
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References | 
|---|---|---|---|---|---|
| Cardiac arrhythmia syndrome with or without skeletal muscle weakness | AR | Cardiovascular | Individuals may present with severe cardiac manifestations, including arrhythmias, syncope, and sudden death, and surveillance, preventive measures (eg, including avoidance of dangerous or excacerbating factors), and treatment (eg, including interventions such as medical treatment with beta-blockers or ICD placement) may allow early and beneficial management, which may decrease morbidity and mortality | Cardiovascular; Musculoskeletal; Neurologic | 22422768; 25922419; 30649896 | 
ClinVar
This is a list of variants' phenotypes submitted to 
- Catecholaminergic_polymorphic_ventricular_tachycardia_1 (954 variants)
- Cardiovascular_phenotype (516 variants)
- not_provided (211 variants)
- Catecholaminergic_polymorphic_ventricular_tachycardia_5 (128 variants)
- not_specified (84 variants)
- TRDN-related_disorder (21 variants)
- Catecholaminergic_polymorphic_ventricular_tachycardia (12 variants)
- EBV-positive_nodal_T-_and_NK-cell_lymphoma (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRDN gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006073.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 11 | 170 | 181 | |||
| missense | 412 | 59 | 476 | |||
| nonsense | 21 | 32 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 12 | 17 | 21 | 50 | ||
| splice donor/acceptor (+/-2bp) | 15 | 44 | 61 | |||
| Total | 22 | 41 | 509 | 229 | 0 | 
Highest pathogenic variant AF is 0.00006237709
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| TRDN | protein_coding | protein_coding | ENST00000398178 | 41 | 420756 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 8.36e-22 | 0.0920 | 124508 | 2 | 127 | 124637 | 0.000518 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.0770 | 294 | 290 | 1.01 | 0.0000136 | 4687 | 
| Missense in Polyphen | 60 | 59.054 | 1.016 | 1102 | ||
| Synonymous | 0.0815 | 93 | 94.0 | 0.989 | 0.00000487 | 1180 | 
| Loss of Function | 1.46 | 39 | 50.1 | 0.778 | 0.00000242 | 826 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.00149 | 0.00148 | 
| Ashkenazi Jewish | 0.00 | 0.00 | 
| East Asian | 0.000341 | 0.000334 | 
| Finnish | 0.00 | 0.00 | 
| European (Non-Finnish) | 0.000551 | 0.000531 | 
| Middle Eastern | 0.000341 | 0.000334 | 
| South Asian | 0.00134 | 0.00118 | 
| Other | 0.000356 | 0.000330 | 
dbNSFP
Source: 
- Function
- FUNCTION: Contributes to the regulation of lumenal Ca2+ release via the sarcoplasmic reticulum calcium release channels RYR1 and RYR2, a key step in triggering skeletal and heart muscle contraction. Required for normal organization of the triad junction, where T-tubules and the sarcoplasmic reticulum terminal cisternae are in close contact (By similarity). Required for normal skeletal muscle strength. Plays a role in excitation- contraction coupling in the heart and in regulating the rate of heart beats. {ECO:0000250|UniProtKB:E9Q9K5, ECO:0000269|PubMed:22422768}.;
- Disease
- DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness (CPVT5) [MIM:615441]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, or sudden death after physical activity or emotional stress. Some patients have muscle weakness. CPVT5 inheritance is autosomal recessive. {ECO:0000269|PubMed:22422768}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Stimuli-sensing channels;Ion channel transport;Ion homeostasis;Transport of small molecules;Cardiac conduction;Muscle contraction (Consensus) 
Recessive Scores
- pRec
- 0.159
Intolerance Scores
- loftool
- 0.861
- rvis_EVS
- 1.98
- rvis_percentile_EVS
- 97.61
Haploinsufficiency Scores
- pHI
- 0.182
- hipred
- N
- hipred_score
- 0.203
- ghis
- 0.396
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.275
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | High | Medium | High | 
| Cancer | High | High | High | 
Mouse Genome Informatics
- Gene name
- Trdn
- Phenotype
- muscle phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- cellular calcium ion homeostasis;muscle contraction;response to bacterium;regulation of cell communication by electrical coupling;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;cytoplasmic microtubule organization;ion transmembrane transport;regulation of release of sequestered calcium ion into cytosol;heart contraction;negative regulation of ryanodine-sensitive calcium-release channel activity;positive regulation of ryanodine-sensitive calcium-release channel activity;regulation of cardiac muscle cell membrane potential;endoplasmic reticulum membrane organization;positive regulation of cell communication by electrical coupling involved in cardiac conduction;regulation of cardiac conduction
- Cellular component
- endoplasmic reticulum;cytosol;plasma membrane;junctional sarcoplasmic reticulum membrane;integral component of membrane;sarcoplasmic reticulum;junctional membrane complex;sarcoplasmic reticulum membrane;sarcoplasmic reticulum lumen
- Molecular function
- signaling receptor binding;protein binding;protein binding, bridging;ion channel binding